RNU6-1212P

Across TCGA pan-cancer cohorts, RNU6-1212P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU6-1212P data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RNU6-1212P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1212P expression acts as an unfavorable survival marker, although some lineages such as ACC and THCA show a favorable association.

READ, PAAD, and LGG are the cancer types where RNU6-1212P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	All	0.166	0.822	<.001	72	view →
PAAD	DFS	Tertile	All	0.068	0.468	<.001	36	view →
LGG	OS	Tertile	All	0.191	0.457	<.001	36	view →
KIRP	DFS	Tertile	II,III,IV	0.166	0.713	.001	24	view →
SARC	DFS	Tertile	All	0.105	0.401	.026	12	view →
STAD	OS	Tertile	III,IV	0.201	0.535	.046	9	view →
ACC	DFS	Tertile	III,IV	1.000	0.405	.045	6	view →
THCA	DFS	Tertile	All	1.000	0.928	.039	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU6-1212P–READ (OS)

Open the READ breakdown →